País: Canadá
Língua: inglês
Origem: Health Canada
PHENAZOPYRIDINE HYDROCHLORIDE
BAUSCH HEALTH, CANADA INC.
G04BX06
PHENAZOPYRIDINE
100MG
TABLET
PHENAZOPYRIDINE HYDROCHLORIDE 100MG
ORAL
250ML
Prescription
ANTIPRURITICS AND LOCAL ANESTHETICS
Active ingredient group (AIG) number: 0106949001; AHFS:
APPROVED
2004-09-08
PRESCRIBING INFORMATION PR PHENAZO ® Phenazopyridine Hydrochloride Tablets 100 mg and 200 mg Tablets URINARY ANALGESIC BAUSCH HEALTH, CANADA INC. DATE OF REVISION: 2150 St-Elzear Blvd. West November 20, 2020 Laval, Quebec H7L 4A8 Control No.: 245653 _ _ _ _ _Pr_ _PHENAZO _ _®_ _ Prescribing Information Page 2 of 16_ TABLE OF CONTENT PART I: HEALTH PROFESSIONAL INFORMATION .......................................................... 3 SUMMARY PRODUCT INFORMATION ......................................................................... 3 INDICATIONS AND CLINICAL USE ............................................................................... 3 CONTRAINDICATIONS .................................................................................................... 4 WARNINGS AND PRECAUTIONS .................................................................................. 4 ADVERSE REACTIONS .................................................................................................... 6 DRUG INTERACTIONS ..................................................................................................... 6 DOSAGE AND ADMINISTRATION ................................................................................. 7 OVERDOSAGE ................................................................................................................... 7 ACTION AND CLINICAL PHARMACOLOGY ............................................................... 8 STORAGE AND STABILITY ............................................................................................ 8 DOSAGE FORMS, COMPOSITION AND PACKAGING ................................................ 8 PART II: SCIENTIFIC INFORMATION ................................................................................. 10 PHARMACEUTICAL INFORMATION .......................................................................... 10 DETAILED PHARMACOLOGY ...................................................................................... 11 TOXICOLOGY .......................... Leia o documento completo